Pharmaceuticals

Controlling for Particulate Matter in Injectable Drug Products

Contamination of Injectable drug products

Particulate matter in injectable drug products have been the reason for many recent drug recalls. In this blog post, Desmond Hunt, Ph.D., discusses sources of particulate matter and how to control them in the manufacturing process. 

Share

The Human Impact of Counterfeit and Substandard Medicines

Human impact of substandard medicines

To help illustrate the true threat of counterfeit and substandard medicines, and demonstrate why USP and so many other organizations are working to improve drug quality, we offer this first-hand story about two near-fatal encounters with bad drugs.

Share

Less is More: Modernizing Quality Standards for Over-The-Counter Drugs

Maintaining current quality standards for over-the-counter medicines

Given the wide public exposure and access to over-the-counter medicines, a major focus for USP is a sustainable strategy which helps ensure that quality standards for OTC products remain current at all times.

Share

Pages